Hepatitis C virus (HCV) genotype 1b displays higher genetic variability of hypervariable region 1 (HVR1) than genotype 3.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
06 09 2019
06 09 2019
Historique:
received:
10
05
2019
accepted:
20
08
2019
entrez:
8
9
2019
pubmed:
8
9
2019
medline:
23
10
2020
Statut:
epublish
Résumé
Hepatitis C virus (HCV) is characterized by high genetic variability, which is manifested both at the inter-host and intra-host levels. However, its role in the clinical course of infection is less obvious. The aim of the present study was to determine the genetic variability of HCV HVR1 (hypervariable region 1) of genotype 1b and 3 in plasma of blood donors in the early seronegative stage of infection (HCV-RNA+, anti-HCV-) and in samples from chronically infected patients using next-generation sequencing. Sequencing errors were corrected, and haplotypes inferred using the ShoRAH software. Genetic diversity parameters (intra-host number of variants, number of nucleotide substitutions and diversity per site) were assessed by DNA SP and MEGA. During the early infection, the number of variants were significantly lower in subjects infected with genotype 3 than with genotype 1b (p < 0.02). Similarly, intra-host number of variants, number of nucleotide substitutions and diversity per site were lower in genotype 3 chronic infection (p < 0.0005). In addition, early infection was characterized by significantly lower HVR1 variability values (p < 0.04) when compared to chronic infection for both genotypes. It seems that the observed differences in HVR1 variability represent an inherent property of particular viral genotypes.
Identifiants
pubmed: 31492939
doi: 10.1038/s41598-019-49258-y
pii: 10.1038/s41598-019-49258-y
pmc: PMC6731259
doi:
Substances chimiques
Nucleotides
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
12846Références
J Viral Hepat. 2000 Jul;7(4):250-7
pubmed: 10886533
J Clin Microbiol. 2004 Sep;42(9):4223-9
pubmed: 15365015
BMC Bioinformatics. 2011 Apr 26;12:119
pubmed: 21521499
J Med Virol. 2001 Nov;65(3):505-9
pubmed: 11596085
Mol Biol Evol. 2011 Oct;28(10):2731-9
pubmed: 21546353
Nat Rev Genet. 2008 Apr;9(4):267-76
pubmed: 18319742
Microbiol Mol Biol Rev. 2012 Jun;76(2):159-216
pubmed: 22688811
Virology. 1992 May;188(1):331-41
pubmed: 1314459
PLoS One. 2010 Oct 25;5(10):e13619
pubmed: 21049051
PLoS Pathog. 2009 Jan;5(1):e1000274
pubmed: 19165325
Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7
pubmed: 18490657
Hepatology. 1993 Dec;18(6):1293-9
pubmed: 8244252
Transfusion. 2004 Dec;44(12):1706-10
pubmed: 15584984
J Virol. 2004 Oct;78(19):10582-7
pubmed: 15367625
J Virol. 2009 Nov;83(22):11456-66
pubmed: 19740991
Bioinformatics. 2009 Jun 1;25(11):1451-2
pubmed: 19346325
Nucleic Acids Res. 2010 Nov;38(21):7400-9
pubmed: 20671025
Clin Exp Hepatol. 2016 Dec;2(4):144-148
pubmed: 28856279
J Hepatol. 1998 Jun;28(6):939-44
pubmed: 9672167
Hepatology. 2014 Jan;59(1):318-27
pubmed: 24115039
Biomed Res Int. 2013;2013:626083
pubmed: 23710455
Virology. 2006 Sep 1;352(2):357-67
pubmed: 16781757
J Virol. 2005 Apr;79(7):4340-6
pubmed: 15767434
BMC Infect Dis. 2014 Jul 13;14:389
pubmed: 25016390
PLoS Pathog. 2011 Sep;7(9):e1002243
pubmed: 21912520
Semin Liver Dis. 2000;20(1):103-26
pubmed: 10895435
Science. 2000 Apr 14;288(5464):339-44
pubmed: 10764648
J Clin Virol. 2013 Oct;58(2):346-50
pubmed: 23523339
PLoS Pathog. 2012;8(8):e1002880
pubmed: 22927816
Gastroenterology. 2004 Sep;127(3):764-76
pubmed: 15362033